Tezspire 210 MG/1.91 ML syring 1.91ML
Ended Awarded
- Contract number
- SPE2DR26FZ61Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,396
Award facts
- Contract value 100% obligated
- $49,395.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,395.60 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of November 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tezspire is a monoclonal antibody treatment indicated for moderate-to-severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, representing specialized pharmaceutical procurement within the military healthcare supply chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates established capability to fulfill complex pharmaceutical procurement requirements through open competition and serves as a critical vendor for federal medical supply needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FZ61Z?
SPE2DR26FZ61Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FZ61Z worth?
The government has obligated $49,396 on SPE2DR26FZ61Z.
Is contract SPE2DR26FZ61Z an order under another contract?
Yes. SPE2DR26FZ61Z is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ61Z competed?
The extent of competition for SPE2DR26FZ61Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award